300015.SZ vs DIVISLAB.NS — which is stronger right now?
Same dated snapshot (2026-09-01): 300015.SZ quality —/100 vs DIVISLAB.NS —/100; engine WAIT vs LONG. The comparison below is computed, dated, and auditable — not an opinion.
| Snapshot | 2026-09-01 · source: tencent | |
|---|---|---|
| 300015.SZ (Aier Eye Hospital) | DIVISLAB.NS (Divi's Laboratories) | |
| Market / sector | ashare · Healthcare Svcs | in · Pharma |
| Price | ¥8.52 | ₹9,121 |
| Quality score | —/100 | —/100 |
| Engine signal | WAIT · 31 bars · uPnL +0.0% | LONG · 218 bars · uPnL +40.9% |
| Total return | -33.6% | +25.3% |
Thesis-break template (Healthcare Svcs)
flagship drug losing exclusivity; pivotal trial failure; pricing-policy shifts; payer consolidation
Cite this page
Balance Labs Research Desk (2026-09-01). "300015.SZ vs DIVISLAB.NS — which is stronger right now?." balancelabs.app · https://balancelabs.app/stocks/compare/300015.sz-vs-divislab.ns · CC BY 4.0
Ask anything
Ask AI: 300015.SZ vs DIVISLAB.NS?What breaks the 300015.SZ thesis?What breaks the DIVISLAB.NS thesis?
30 free credits monthly · no card required · research support, not advice
← compare hub · snapshot 2026-09-01 · not investment advice